Mindaugas Jurgutis

711 citations
7 papers · 447 indexed · 1 hit paper · h-index 5
Topics
Chronic Myeloid Leukemia Treatments (6 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers)Chronic Lymphocytic Leukemia Research (2 papers)

In The Last Decade

Mindaugas Jurgutis

7 papers receiving 443 citations

Hit Papers

Safety and Efficacy of Fedratinib in Patients With Primar...20152026201820222015100200300

Peers

Mindaugas Jurgutis
Comparison fields: 5 of 44
  • Genetics 373
  • Hematology 281
  • Molecular Biology 203
  • Rheumatology 137
  • Oncology 62
Replace Elena Mishchenko with:
Elena Mishchenko Israel
Emanuil Gheorghita Romania
D. W. Kim United States
Clara Ricci Italy
Hyacinthe Johnson‐Ansah France
Amity Frede Australia
Uwe Schwindel Germany
Rafal Falinski United States
Nataliia Glushko Ukraine
Cristina Bucelli Italy
Mindaugas Jurgutis relative to Elena Mishchenko Israel Elena Mishchenko's profile →
Citations per field
00.5×1.5×
Elena Mishchenko · 1×
Citations per year

Countries citing papers authored by Mindaugas Jurgutis

Since Specialization
Citations

This map shows the geographic impact of Mindaugas Jurgutis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindaugas Jurgutis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindaugas Jurgutis more than expected).

Fields of papers citing papers by Mindaugas Jurgutis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindaugas Jurgutis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindaugas Jurgutis. The network helps show where Mindaugas Jurgutis may publish in the future.

Co-authorship network of co-authors of Mindaugas Jurgutis

This figure shows the co-authorship network connecting the top 25 collaborators of Mindaugas Jurgutis. A scholar is included among the top collaborators of Mindaugas Jurgutis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindaugas Jurgutis. Mindaugas Jurgutis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 40
2 2
3 14
4
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosisbreakdown →
340
5 3
6 27
7 21

About Mindaugas Jurgutis

Mindaugas Jurgutis is a scholar working on Genetics, Hematology and Rheumatology, having authored 7 papers that have together received 447 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Genetics (373 citations), Hematology (281 citations) and Rheumatology (137 citations). Mindaugas Jurgutis has collaborated with scholars based in United Kingdom, Hungary and United States. Frequent co-authors include Alessandro M. Vannucchi, Éric Jourdan, Claire Harrison, Mark W. Drummond, Tamás Masszi, Elena Mishchenko, Ayalew Tefferi, Animesh Pardanani, Ruben A. Mesa and Donald Milligan. Their work appears in journals such as Blood, British Journal of Haematology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026